These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 15854671

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
    Li B, Simmons A, Du T, Lin C, Moskalenko M, Gonzalez-Edick M, VanRoey M, Jooss K.
    Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
    [Abstract] [Full Text] [Related]

  • 4. Induction of T-cell apoptosis in rats by genetically engineered glioma cells expressing granulocyte-macrophage colony-stimulating factor and B7.1.
    Tseng SH, Chen Y, Chang CJ, Tai KF, Lin SM, Hwang LH.
    Clin Cancer Res; 2005 Feb 15; 11(4):1639-49. PubMed ID: 15746069
    [Abstract] [Full Text] [Related]

  • 5. Granulocyte/macrophage-colony stimulating factor produced by recombinant avian poxviruses enriches the regional lymph nodes with antigen-presenting cells and acts as an immunoadjuvant.
    Kass E, Panicali DL, Mazzara G, Schlom J, Greiner JW.
    Cancer Res; 2001 Jan 01; 61(1):206-14. PubMed ID: 11196163
    [Abstract] [Full Text] [Related]

  • 6. An agonist antibody specific for CD40 induces dendritic cell maturation and promotes autologous anti-tumour T-cell responses in an in vitro mixed autologous tumour cell/lymph node cell model.
    Hunter TB, Alsarraj M, Gladue RP, Bedian V, Antonia SJ.
    Scand J Immunol; 2007 May 01; 65(5):479-86. PubMed ID: 17444959
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T, Iwahashi M, Nakamura M, Matsuda K, Naka T, Nakamori M, Ueda K, Ishida K, Yamaue H.
    Int J Oncol; 2006 Apr 01; 28(4):947-53. PubMed ID: 16525645
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hydrocortisone inhibits granulocyte-macrophage colony-stimulating factor production from normal human peripheral blood mononuclear cells and CD3+ T cells.
    Chikkappa G, Lansing LS, Chu RC, Pasquale D.
    Exp Hematol; 1998 Dec 01; 26(13):1240-6. PubMed ID: 9845380
    [Abstract] [Full Text] [Related]

  • 11. Sustained release of granulocyte-macrophage colony-stimulating factor from a modular peptide-based cancer vaccine alters vaccine microenvironment and enhances the antigen-specific T-cell response.
    Nguyen CL, Bui JT, Demcheva M, Vournakis JN, Cole DJ, Gillanders WE.
    J Immunother; 2001 Dec 01; 24(5):420-9. PubMed ID: 11696697
    [Abstract] [Full Text] [Related]

  • 12. Vaccination with leukemia cells expressing cell-surface-associated GM-CSF blocks leukemia induction in immunocompetent mice.
    Ling X, Wang Y, Dietrich MF, Andreeff M, Arlinghaus RB.
    Oncogene; 2006 Jul 27; 25(32):4483-90. PubMed ID: 16547503
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Surgical excision combined with autologous whole tumor cell vaccination is an effective therapy for murine neuroblastoma.
    Ohashi K, Kobayashi G, Fang S, Zhu X, Antonia SJ, Krieg AM, Sandler AD.
    J Pediatr Surg; 2006 Aug 27; 41(8):1361-8. PubMed ID: 16863838
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mechanisms of immune suppression in patients with head and neck cancer: presence of CD34(+) cells which suppress immune functions within cancers that secrete granulocyte-macrophage colony-stimulating factor.
    Pak AS, Wright MA, Matthews JP, Collins SL, Petruzzelli GJ, Young MR.
    Clin Cancer Res; 1995 Jan 27; 1(1):95-103. PubMed ID: 9815891
    [Abstract] [Full Text] [Related]

  • 17. Targeting of IL-2 and GM-CSF immunocytokines to a tumor vaccine leads to increased anti-tumor activity.
    Fournier P, Aigner M, Schirrmacher V.
    Int J Oncol; 2011 Jun 27; 38(6):1719-29. PubMed ID: 21424118
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Benefits of gene transduction of granulocyte macrophage colony-stimulating factor in cancer vaccine using genetically modified dendritic cells.
    Ojima T, Iwahashi M, Nakamura M, Matsuda K, Nakamori M, Ueda K, Naka T, Katsuda M, Miyazawa M, Yamaue H.
    Int J Oncol; 2007 Oct 27; 31(4):931-9. PubMed ID: 17786327
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.